We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actavis, Allergan Deal Drives Record-Setting Quarter
Actavis’ $68 billion acquisition of Allergan drove a record-setting $166.3 billion in pharma deals closed during the first quarter of 2015, a new report from PricewaterhouseCoopers shows.